The Lancet's COVID-19 Resource Centre: A locally sustainable approach to COVID-19 testing in Africa and more

New COVID-19 Content is Now Available

Dear Victor Norberto, New this week: A Comment published in The Lancet Microbe elucidates the impressive achievement of African countries on COVID-19 testing. The authors explain that the Africa Centres for Disease Control and Prevention (CDC), through the Partnership to Accelerate COVID-19 Testing in Africa (PACT) programme, did 3·4 million COVID-19 tests in Africa by June, 2020. Although this figure translates to a mere 1700 tests per million people compared with 103 000 tests per million people in Italy and 195 000 in the UK, this outcome is a great achievement on a continent starved of economic and health resources. Read the Comment here.  We hope you find the Resource Centre on COVID-19 to be informative.  We want to make sure that you receive information that is interesting and relevant to you, so if you prefer to receive updates to include new Chinese translations please click here. Yours sincerely, The Lancet

2020 Virtual National Health Research Forum

Join Research! America for the 2020 Virtual National Health Research Forum, Straight Talk: Securing a Science-Strong Future. Richard Horton, Editor-in-Chief of The Lancet, will be speaking in a panel on Public Health Preparedness–Hard Lessons of COVID19 during a session moderated by Georges Benjamin, Executive Director of the American Public Health Association. Thu, Sep 10, 2020 11:50 pm ET | 4:50 pm BST Register to attend this Forum

NEW content on COVID-19

The Lancet Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial Azithromycin for severe COVID-19 Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access The Lancet Microbe COVID-19 and fungal infection: the need for a strategic approach Open Access A locally sustainable approach to COVID-19 testing in Africa Open Access In preparation for a COVID-19-influenza double epidemic Open Access The Lancet Respiratory Medicine COVID-19 vaccine trials in Africa The Russian vaccine for COVID-19 The Lancet Rheumatology Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment Mavrilimumab for severe COVID-19 Mavrilimumab for severe COVID-19 Mavrilimumab for severe COVID-19 – Authors' reply EClinicalMedicine Multisystem inflammatory syndrome in children: A systematic review Open Access The Lancet Regional Health - Western Pacific An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency? Open Access